Answers are grounded in this paper and cite their sources.
Five of 64 recipients of HLA-identical sibling marrow allografts who were given cyclosporin (CSP) to minimize graft-versus-host disease posttransplant had a serious neurological illness thought to be due to CSP. Characteristic clinical features included a motor spinal cord syndrome, a cerebellar-like syndrome, and mental confusion. All five recovered when the CSP dose was reduced or the drug was stopped.
No takes yet. Share an insight, caveat, or question.
Atkinson et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: